HUMAN EPIDIDYMIS PROTEIN 4 AS BIOMARKER FOR THE DIFFERENTIATION BETWEEN PRIMARY OVARIAN CANCER AND OVARIAN METASTASES

被引:0
作者
Boldingh, Q. J. J. [1 ]
Stiekema, A. [1 ]
Lok, C. A. R. [1 ]
Boot, H. [2 ]
van Driel, W. J. [1 ]
Kenter, G. G. [1 ]
Korse, C. M. [2 ]
机构
[1] Dutch Canc Inst, Ctr Gynecol Oncol Amsterdam, Amsterdam, Netherlands
[2] Dutch Canc Inst, Antoni van Leeuwenhoek Hosp, Amsterdam, Netherlands
关键词
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
IGCSM-0869
引用
收藏
页码:280 / 281
页数:2
相关论文
共 50 条
  • [31] Serum Human Epididymis Protein 4 and Risk for Ovarian Malignancy Algorithm as New Diagnostic and Prognostic Tools for Epithelial Ovarian Cancer Management
    Bandiera, Elisabetta
    Romani, Chiara
    Specchia, Claudia
    Zanotti, Laura
    Galli, Claudio
    Ruggeri, Giuseppina
    Tognon, Germana
    Bignotti, Eliana
    Tassi, Renata A.
    Odicino, Franco
    Caimi, Luigi
    Sartori, Enrico
    Santin, Alessandro D.
    Pecorelli, Sergio
    Ravaggi, Antonella
    CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION, 2011, 20 (12) : 2496 - 2506
  • [32] Usefulness of human epididymis protein 4 in predicting optimal cytoreductive therapy in patients with advanced ovarian cancer
    Paunovic, Vesna
    Protrka, Zoran
    Ardalic, Daniela
    Paunovic, Tomislav
    JOURNAL OF BUON, 2017, 22 (01): : 29 - 33
  • [33] Interaction of CD147 and human epididymis protein 4 promotes invasion and metastasis of ovarian cancer
    Gao, Lingling
    Nie, Xin
    Rui, Gou
    Qi, Yue
    Liu, Juanjuan
    Lin, Bei
    JOURNAL OF CANCER, 2021, 12 (24): : 7422 - 7435
  • [34] Analysis of the gene expression profile in response to human epididymis protein 4 in epithelial ovarian cancer cells
    Zhu, Liancheng
    Guo, Qian
    Jin, Shan
    Feng, Huilin
    Zhuang, Huiyu
    Liu, Cong
    Tan, Mingzi
    Liu, Juanjuan
    Li, Xiao
    Lin, Bei
    ONCOLOGY REPORTS, 2016, 36 (03) : 1592 - 1604
  • [35] Human epididymis protein 4 in association with Annexin II promotes invasion and metastasis of ovarian cancer cells
    Zhuang, Huiyu
    Tan, Mingzi
    Liu, Juanjuan
    Hu, Zhenhua
    Liu, Dawo
    Gao, Jian
    Zhu, Liancheng
    Lin, Bei
    MOLECULAR CANCER, 2014, 13
  • [36] EFFICACY OF HUMAN EPIDIDYMIS PROTEIN 4 AND CANCER ANTIGEN 125 IN MONITORING OF RESPONSIVENESS TO CHEMOTHERAPY IN EPITHELIAL OVARIAN CANCER PATIENTS
    Yanaranop, M.
    Aryuwat, S.
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2018, 28 : 873 - 873
  • [37] Human epididymis protein 4 (HE4) plays a key role in ovarian cancer cell adhesion and motility
    Lu, Renquan
    Sun, Xinghui
    Xiao, Ran
    Zhou, Lei
    Gao, Xiang
    Guo, Lin
    BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2012, 419 (02) : 274 - 280
  • [38] Human epididymis protein 4 for differential diagnosis between benign gynecologic disease and ovarian cancer: a systematic review and meta-analysis
    Lin, JiaYing
    Qin, JinBao
    Sangvatanakul, Voramon
    EUROPEAN JOURNAL OF OBSTETRICS & GYNECOLOGY AND REPRODUCTIVE BIOLOGY, 2013, 167 (01) : 81 - 85
  • [39] Sprouty 2 protein, but not Sprouty 4, is an independent prognostic biomarker for human epithelial ovarian cancer
    Masoumi-Moghaddam, Samar
    Amini, Afshin
    Wei, Ai-Qun
    Robertson, Gregory
    Morris, David L.
    INTERNATIONAL JOURNAL OF CANCER, 2015, 137 (03) : 560 - 570
  • [40] Clinical value of serum human epididymis protein 4 assay in the diagnosis of ovarian cancer: a meta-analysis
    Yang, Zhijun
    Wei, Chunyin
    Luo, Zhaoqing
    Li, Li
    ONCOTARGETS AND THERAPY, 2013, 6 : 957 - 966